Back to top anchor

Evidence-based management of Long COVID

Year:
2022
Duration:
36 months
Approved budget:
$1,399,904.30
Researchers:
Associate Professor Mona Jeffreys
,
Associate Professor Lynne Russell
,
Ms Jenene Crossan
,
Dr Lis Ellison-Loschmann
,
Dr Kirsten Smiler
,
Dr Anna Brooks
,
Dr David Davies-Payne
,
Dr Rosie Dobson
,
Associate Professor Tupa'ilevaililigi Ridvan Firestone
,
Dr Fiona McKenzie
,
Dr Claire O'Loughlin
,
Dr Sarah Rhodes
,
Miss Bailey Yee
,
Fiona Dunford
,
Rochelle Ellison-Lupena
Health issue:
Other (generic health or health services)
Proposal type:
Health Delivery Project
Lay summary
Long COVID (LC) is increasingly recognised as a public health concern, with the magnitude of the problem in Aotearoa New Zealand likely to grow considerably due to the current SARS-CoV-2 Omicron outbreak. We propose a multi-disciplinary study that integrates the disciplines of immunology, kaupapa Māori evaluation, co-design methodology, epidemiology and health services research with the clinical interface. By the end of the project, we will have developed i) a set of bio-markers of immune dysfunction, to contribute to the accurate diagnosis of LC; ii) a template for evidence-based, primary care services, co-designed with people with LC and iii) recommendations for the improvement of existing and development of future LC clinics to further meet the needs of patients. The work will be supported by our extensive network of LC Stakeholders, including people with lived experience of LC, Māori health experts, health professionals, health service researchers and co-design experts.